Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003109
Status:
COMPLETED
Last Update Posted:
2013-04-17
First Post:
1999-11-01
Brief Title:
Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors
Sponsor:
Fox Chase Cancer Center
Organization:
Fox Chase Cancer Center
Organization Data
Organization:
Fox Chase Cancer Center
Class:
OTHER
Study ID:
CDR0000065851
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fox Chase Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |